Abstract |
Specific forms of the lipid ceramide, synthesized by the ceramide synthase enzyme family, are believed to regulate metabolic physiology. Genetic mouse models have established C16 ceramide as a driver of insulin resistance in liver and adipose tissue. C18 ceramide, synthesized by ceramide synthase 1 (CerS1), is abundant in skeletal muscle and suggested to promote insulin resistance in humans. We herein describe the first isoform-specific ceramide synthase inhibitor, P053, which inhibits CerS1 with nanomolar potency. Lipidomic profiling shows that P053 is highly selective for CerS1. Daily P053 administration to mice fed a high-fat diet (HFD) increases fatty acid oxidation in skeletal muscle and impedes increases in muscle triglycerides and adiposity, but does not protect against HFD-induced insulin resistance. Our inhibitor therefore allowed us to define a role for CerS1 as an endogenous inhibitor of mitochondrial fatty acid oxidation in muscle and regulator of whole-body adiposity.
|
Authors | Nigel Turner, Xin Ying Lim, Hamish D Toop, Brenna Osborne, Amanda E Brandon, Elysha N Taylor, Corrine E Fiveash, Hemna Govindaraju, Jonathan D Teo, Holly P McEwen, Timothy A Couttas, Stephen M Butler, Abhirup Das, Greg M Kowalski, Clinton R Bruce, Kyle L Hoehn, Thomas Fath, Carsten Schmitz-Peiffer, Gregory J Cooney, Magdalene K Montgomery, Jonathan C Morris, Anthony S Don |
Journal | Nature communications
(Nat Commun)
Vol. 9
Issue 1
Pg. 3165
(08 21 2018)
ISSN: 2041-1723 [Electronic] England |
PMID | 30131496
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Enzyme Inhibitors
- Fatty Acids
- Sphingolipids
- Oxidoreductases
- dihydroceramide desaturase
|
Topics |
- Animals
- Cell Respiration
(drug effects)
- Diet, High-Fat
- Enzyme Inhibitors
(chemistry, pharmacology)
- Fatty Acids
(metabolism)
- HEK293 Cells
- Humans
- Inhibitory Concentration 50
- Insulin Resistance
- Lipid Metabolism
(drug effects)
- Liver
(drug effects, metabolism)
- Male
- Mice, Inbred C57BL
- Mitochondria
(drug effects, metabolism)
- Muscle, Skeletal
(metabolism)
- Oxidation-Reduction
- Oxidoreductases
(antagonists & inhibitors, metabolism)
- Sphingolipids
(metabolism)
|